Abstract-Numerous adult diseases involving tissues consisting primarily of nondividing cells are associated with changes in DNA methylation. It suggests a pathophysiological role for de novo methylation or demethylation of DNA, which is catalyzed by DNA methyltransferase 3 and ten-eleven translocases. However, the contribution of DNA de novo (de)methylation to these diseases remains almost completely unproven. Broad changes in DNA methylation occurred within days in the renal outer medulla of Dahl SS rats fed a high-salt diet, a classic model of hypertension. Intrarenal administration of anti-DNA methyltransferase 3a/ten-eleven translocase 3 GapmeRs attenuated high salt-induced hypertension in SS rats. The high-salt diet induced differential expression of 1712 genes in the renal outer medulla. Remarkably, the differential expression of 76% of these genes was prevented by anti-DNA methyltransferase 3a/teneleven translocase 3 GapmeRs. The genes differentially expressed in response to the GapmeRs were involved in the regulation of metabolism and inflammation and were significantly enriched for genes showing differential methylation in response to the GapmeRs. These data indicate a significant role of DNA de novo (de)methylation in the kidney in the development of hypertension in SS rats. The findings should help to shift the paradigm of DNA methylation research in diseases involving nondividing cells from correlative analysis to functional and mechanistic studies. (Hypertension.
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NA methylation is a major type of epigenetic modification. It mainly occurs at cytosines in cytosine-guanine (CpG) dinucleotides and can change transcriptional activities and gene expression. De novo DNA methylation is catalyzed by DNA methyltransferase 3a (Dnmt3a) or 3b (Dnmt3b) working with Dnmt3l. 1 The pattern of DNA methylation is maintained during DNA replication primarily by Dnmt1. Removal of DNA methylation, or DNA demethylation, involves the teneleven translocase family (Tet1, Tet2, and Tet3). 2 The role of DNA methylation, including de novo methylation, is well established in embryonic development and cell differentiation. 3 Extensive evidence also exists for associations between changes in DNA methylation in adult tissues and the development of diseases that primarily involve nondividing cells, such as cardiovascular and renal diseases. [4] [5] [6] However, the functional role of de novo DNA methylation or demethylation, collectively called DNA de novo (de)methylation, in these highly prevalent diseases remains nearly completely unproven. 7 Studies investigating causal contribution of DNA de novo (de)methylation to disease is hampered by the lack of specific pharmacological inhibitors. Commonly used inhibitors of DNA methylation, such as decitabine, work as cytidine analogs that are incorporated into DNA during cell division and, thereby, prevent DNA methylation. 8 These agents, therefore, would not inhibit de novo DNA methylation that occurs in terminally differentiated, nondividing cells that dominate organs and organ systems, such as the kidney and the cardiovascular system. Genetic deletion of Dnmt3 is lethal in mice. 1 Mouse models with conditional deletion of Dnmt3 or Tet can be powerful tools, and they are beginning to emerge. However, some of the robust models of cardiovascular disease are only available in rats for which conditional gene deletion remains highly challenging to produce.
Hypertension is the number 1 identifiable risk factor for death worldwide. 9 More than 50% of hypertensive patients have salt sensitive forms of hypertension. 10 The Dahl saltsensitive SS rat is the most commonly used model of human salt-sensitive hypertension. 10 The kidney plays a key role in long-term regulation of arterial blood pressure, as well as the development of salt-induced hypertension in SS rats. 11, 12 We previously reported the first maps of DNA methylation at single-base resolution in the kidneys of SS rats. 13 Distinct patterns of methylation profiles were observed between SS rats and a congenic salt-insensitive rat strain on a 0.4% NaCl diet or after 7 days of a 4% NaCl diet.
In the present study, we extended the previous observations to SS rats under additional experimental conditions. The results indicated substantial and rapid changes in DNA methylation in the kidneys of SS rats in response to dietary changes. We used GapmeR, a modified antisense reagent that can be effective in vivo, 14 to target Dnmt3a and Tet3 in the kidneys of SS rats to attenuate the changes of methylation, including possibly increases and decreases of methylation at different genomic loci. The intrarenal administration of antiDnmt3a/Tet3 GapmeRs resulted in remarkable prevention of salt-induced changes in gene expression and DNA methylation and significantly attenuated salt-induced hypertension.
Methods
Detailed methods are available in the online-only Data Supplement. Raw sequence data and their associated processed files for reduced representation bisulfite sequencing (RRBS) and RNA-sequencing (RNA-seq) experiments have been made publicly available at Gene Expression Omnibus database (GSE114335).
Animals
Unless otherwise indicated, rats were maintained at the Medical College of Wisconsin on the AIN-76A diet (Dyets) with free access to water as described previously. 15 Female rats of 7 to 11 weeks of age were used in the current study.
Reduced Representation Bisulfite Sequencing
DNA methylation profile analysis was performed in renal outer medulla tissues from individual rats (7 groups, n=3-4 per group) using multiplexed RRBS as described previously.
13,16

Western Blot
Western blot was performed as described previously. 17 Coomassie blue staining of the entire membrane was used for normalization. 15, [17] [18] [19] 
Immunohistochemistry
Immunohistochemistry analysis was performed largely as described previously.
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Renal Medullary Interstitial Infusion and Measurement of Arterial Blood Pressure in Conscious, Freely Moving Rats
Catheterization to allow renal medullary interstitial delivery of GapmeR and measurement of arterial blood pressure in conscious, freely moving rats were performed as described previously. 21, 22 Rats were uninephrectomized to ensure the remaining kidney receiving GapmeR injection was the sole determinant of kidney function. Similar methods of renal medullary interstitial injection have been used by several laboratories to achieve medulla targeted, intrarenal delivery of compounds. [23] [24] [25] [26] [27] We chose to target the renal medulla because this tissue region plays a particularly important physiological role in the development of salt-sensitive hypertension.
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In Vivo Administration of GapmeR
GapmeRs targeting Dnmt3a and Tet3 were pooled and injected into the kidneys of conscious, freely moving rats via the renal interstitial catheter described above. The dose was 2 mg/kg body weight for each GapmeR in a total volume of 100 μL. Control rats were injected with a scrambled GapmeR at 4 mg/kg body weight in 100 μL. In some experiments, GapmeR targeting Dnmt3a only or the scrambled GapmeR were used at the dose of 2 mg/kg body weight.
RNA-Seq Library Preparation and Sequencing
RNA-seq libraries were prepared with total RNA from individual rats (3 groups, n=3-4 per group) and sequenced as we described previously 13 with modifications.
Cloning-Based Sequencing of Bisulfite-Treated DNA
Polymerase chain reaction primers were designed to produce a 377 bp amplicon covering a methylation region of interest. Purified polymerase chain reaction products from bisulfite-treated DNA were ligated with pGEM-T Easy Vector (Promega) and transformed into DH5α competent cells. Approximately 10 colonies were picked from each sample and Sanger-sequenced to determine the methylation rate of each CpG site within the region.
Analysis of RNA-Seq Data
RNA-seq data were analyzed as described previously 13 with modifications.
Analysis of Methylation Sequencing Data
RRBS data were analyzed as described previously 13 with modifications, using MethylCoder, 29 Genomic short-read nucleotide alignment program, 30 and metilene. 31 Differentially methylated regions (DMRs) were tested for significance using an additional modified Wilcoxon rank-sum test. A DMR is required to contain at least 5 CpG sites and exhibit a methylation rate difference of >5% between 2 tested groups.
Statistical Analysis
Differential expression of genes, DMRs, and Gene Ontology (GO) term enrichment was identified using false discovery rate <0.05 by the Benjamini-Hochberg method. Blood pressure and protein abundance data are presented as mean±SEM. Two-sample t test was used to test the difference between 2 groups. Blood pressure data were tested using 2-way repeated measure ANOVA followed by HolmSidak test.
Results
Broad Changes in DNA Methylation in the Renal Outer Medulla in Response to a High-Salt Diet or Diets That Alter Blood Pressure Salt Sensitivity
We reported previously that DNA methylation profiles in the renal outer medulla of SS rats changed significantly in response to 7 days of a high-salt (HS) diet and in a way that was distinct from the response of salt-insensitive SS.13 BN26 rats. 13 Again, we chose to focus the analysis on the renal outer medulla because of its important physiological role in the development of salt-sensitive hypertension. 28 We began the present study by examining whether other dietary conditions that altered blood pressure or salt sensitivity would also change DNA methylation profiles in the renal outer medulla.
We studied methylation profiles in 4 groups of SS rats (n=3-4). One group was obtained from a colony maintained on a purified diet, AIN-76A, containing 0.4% NaCl at the Medical College of Wisconsin (MCW) and fed the same diet since weaning until 8 weeks old when the tissues were collected for analysis. This group was designated MCW low salt (LS). Another group was obtained from a colony maintained on a nonpurified diet, 5L2F, containing 0.75% NaCl at Charles River Laboratories (CRL) and fed the same diet since receipt until 8 weeks old, designated CRLLS. Additional groups of SS rats from each colony were fed an AIN-76A diet containing 4% NaCl for 14 days starting at 6 weeks of age. These groups were designated MCWHS and CRLHS.
The MCW and CRL SS colonies have essentially identical genetic backgrounds. 32 We have reported that mean arterial pressure increased from ≈105 mm Hg in MCWLS rats to 140 mm Hg in MCWHS rats. The increase was substantially attenuated in CRL rats, only changing from ≈102 mm Hg in CRLLS to 110 mm Hg in CRLHS. 32 We examined genome-wide DNA methylation profiles at single-base resolution in the renal outer medulla in these 4 groups of SS rats using RRBS. Quality metrics of the RRBS data and bisulfite conversion rates are available in Tables S1 and S2 in the online-only Data Supplement. On average, ≈10 million reads per library were uniquely mapped to the reference genome, and the bisulfite conversion rate was 99.6%. Approximately 890 000 CpG sites were covered by at least 10 reads. The complete RRBS data are available in Gene Expression Omnibus database (GSE114335).
We observed broad differences in DNA methylation profiles between the 4 groups of rats. Clustering of the samples based on the normalized RRBS data was consistent with the experimental grouping of the samples ( Figure 1A and 1B). Clustering based on original RRBS data without normalization produced similar groupings ( Figure S1 ). Several hundred DMRs were identified between the 2 colonies of SS rats or the same colony of rats on LS and HS diets. Approximately a quarter of the DMRs were located in transcriptional start site regions, a third in intragenic regions, and the remainder in intergenic regions ( Figure S2 ; Table S3 ). Genes associated with the DMRs in transcriptional start site or intragenic regions in each of the 4 comparisons were enriched for genes associated with the GO term of sequence-specific DNA binding (false discovery rate <0.05; Figure S2 ; Table S4 ). In addition, genes bearing DMRs between CRLHS and MCWHS were enriched for GO terms SH3 and PDZ domain binding and transcription activator activity, CRLLS and CRLHS for SH3 domain binding and protein binding, and MCWLS and MCWHS for protein binding.
The DMRs showed, or tended to show, higher methylation levels in rats with higher blood pressure or higher levels of blood pressure salt sensitivity. Specifically, methylation levels of DMRs were significantly higher in CRLHS than CRLLS, regardless of where the DMRs were located relative to genes ( Figure 1C ). The same was true for MCWHS compared with MCWLS ( Figure 1D ). A tendency for higher methylation levels was observed in DMRs located in intragenic or intergenic regions in MCWLS and MCWHS compared with CRLLS and CRLHS ( Figure 1E and 1F), respectively, although the differences did not reach statistical significance.
Expression of Dnmt3 and Tet Isoforms in the Kidneys of SS Rats
The renal outer medulla consists primarily of terminally differentiated, nondividing cells, which suggests the robust changes in DNA methylation in the renal outer medulla we observed in the present and previous studies 13 were likely the consequence of de novo DNA methylation or demethylation. Other possible contributors included changes in infiltrating cells and imperfect fidelity of methylation maintenance during DNA replication in the small number of dividing cells that may be present in the renal outer medulla. The remainder of the study focused on testing the role of de novo DNA (de)methylation. Dnmt3 and Tet families of enzymes catalyze de novo DNA methylation and demethylation, respectively. Each family has several members. We examined the protein abundance of Dnmt3a, Dnmt3b, Tet1, Tet2, and Tet3 in the renal medulla of SS (from the MCW colony) and salt-insensitive SS.13 BN rats.
33 Dnmt3a appeared to be more abundantly expressed in the renal medulla than Dnmt3b (Figure 2A and 2B). In addition, Dnmt3a abundance was significantly higher in SS rats fed the 4% NaCl diet for 7 days, compared with SS.13 BN rats on the same diet ( Figure 2A ). Dnmt3a was not differentially expressed between the rat strains on the 0.4% NaCl diet, suggesting downregulation of Dnmt3a might be a protective mechanism that is used by SS.13
BN26 rats in response to the HS diet but not by SS rats.
Tet1 and Tet2 were detected but were not significantly differentially expressed ( Figure 2C and 2D ). Tet3 appeared to show differential expression, but the detection of Tet3 by Western blot was questionable. The band closest to the expected molecular weight of rat Tet3 (195 kDa) showed significantly higher abundance in SS rats maintained on the 0.4% NaCl diet compared with SS rats fed the 4% NaCl diet for 7 days or SS.13 BN rats on either diet (n=3, P<0.05). However, several additional bands were detected around 195 kDa. It is often more difficult to find high-quality antibodies for rat proteins than for human or mouse proteins. mRNA encoding Tet3 was expressed at an abundance level of ≈15 to 20 fragments per kilobase per million reads in the renal outer medulla according to previous RNA-seq analysis, compared with 1 to 2 fragments per kilobase per million reads for Tet1. 13 Immunohistochemistry analysis was performed in kidneys from Sprague-Dawley rats to qualitatively examine the renal distribution of Dnmt3 and Tet isoforms. Dnmt3a, Dnmt3b, Tet1, and Tet3 were broadly expressed in several tissues in the renal cortex and medulla ( Figure S3 ). Particularly prominent expression was observed for Dnmt3a in distal tubules and Tet1 in the renal medulla. The latter appeared consistent with the strong band in Western blot shown in Figure 2C . Tet2 was barely detectable (Figure S3 ), consistent with the faint band in Western blot ( Figure 2D ). The quality of several of the antibodies used was supported by staining patterns in other rat tissues that were consistent with the literature ( Figure S3) .
We focused the subsequent interventional experiments on Dnmt3a and Tet3 because Dnmt3a was expressed at higher levels in SS rats (Figure 2A) , and Tet3 was abundant and appeared to be differentially expressed.
Intrarenal Administration of Anti-Dnmt3a/Tet3 GapmeRs Attenuates Salt-Induced Hypertension in SS Rats
We administered GapmeRs targeting Dnmt3a and Tet3 directly into the renal medullary interstitium in SS rats. Hypertension likely involves the upregulation of some genes and downregulation of other genes. Similarly, hypertension might involve the increase of methylation (mediated by Dnmt3) at some genomic loci and decrease (mediated by Tet) at other loci. The goal of the combined Dnmt3a/Tet3 GapmeR experiment was to attenuate both the increase (at some loci) and decrease (at other loci) of methylation. The rats were switched to the 4% NaCl diet and tissues collected 7 days later for analysis. Dnmt3a protein abundance in the renal outer medulla was significantly decreased in rats receiving the GapmeRs compared with rats receiving a scrambled control GapmeR ( Figure 3A and 3B). Dnmt3a was knocked down by 38% (P<0.05), which was a robust degree of knockdown for in vivo administration of oligonucleotides in the kidney. Importantly, the degree of knockdown was comparable to the difference of Dnmt3a between SS and SS. 13 BN rats shown in Figure 2A , suggesting the degree of knockdown might be physiologically relevant. In the renal cortex, Dnmt3a was not consistently detectable by Western blot in either experimental group. Dnmt3a protein abundance in the liver ( Figure S4 ) or the heart was not significantly altered by intrarenal administration of the GapmeRs.
Western blot detection of Tet3 was questionable due to the presence of multiple bands, similar to that described in the preceding section. The band closest to the expected molecular weight of rat Tet3 was decreased by 12% in rats treated with GapmeRs targeting Dnmt3a and Tet3 (n=4-5, P<0.05, student t test). In the renal cortex, abundance of the band was decreased by 28% in the treated group (n=4-5, P<0.05, student t test). mRNA levels of Tet3 were not changed at the 7-day time point, which, however, would not rule out changes in protein abundance at 7 days or reduction of mRNA abundance at earlier time points. Before the in vivo experiment, we tested 5 GapmeRs targeting different parts of rat Tet3 mRNA. All 5 were effective in reducing Tet3 mRNA abundance in cultured rat kidney cells NRK-52E ( Figure S5A ). GapmeR number 3 was the most effective and was selected for the in vivo intrarenal administration experiment described above. The GapmeR targeting Dnmt3a was also effective in NRK-52E cells ( Figure S5B ). Although the efficacy in cultured cells does not guarantee efficacy in knocking down protein , and CRLHS and MCWHS (F). MCW, SS rats obtained from a colony maintained on a purified diet, AIN-76A, containing 0.4% NaCl at MCW; CRL, SS rats obtained from a colony maintained on a nonpurified diet, 5L2F, containing 0.75% NaCl at CRL; LS, rats fed the same diet as the diet the respective colony was maintained on until they are 8 wk old when the tissues were collected for analysis; HS, rats fed an AIN-76A diet containing 4% NaCl for 14 d starting at 6 wk of age; TSS, transcriptional start site regions; DMR, differentially methylated regions. *P<0.05; **P<0.01. expression in vivo, the cell culture data support the efficacy of the GapmeR targeting Tet3. Tet3 protein abundance in the liver ( Figure S4 ) or the heart was not significantly altered by intrarenal administration of the GapmeRs.
Together, these data indicated that the intrarenal administration of anti-Dnmt3a/Tet3 GapmeRs resulted in robust, physiologically relevant knockdown of Dnmt3a in the kidney. Tet3 was probably, but not certainly, knocked down. The knockdown effect did not spread to the liver or the heart as described above.
Importantly, intrarenal administration of anti-Dnmt3a/ Tet3 GapmeRs significantly attenuated HS-induced hypertension in SS rats. Mean arterial pressure was significantly lower in the treated group starting on day 4 after the administration of GapmeRs and the initiation of the HS diet ( Figure 3C ). By day 7 on the HS diet, 31% of the HS-induced increase of mean arterial pressure in the control group was prevented in the treated group. This degree of attenuation of hypertension was comparable to that observed in SS.13 BN or SS.13 BN26 rats compared with SS rats. 34, 35 Significant decreases were observed for both systolic and diastolic blood pressures and appeared to be more pronounced for diastolic pressure ( Figure 3D and 3E) . By day 7 on the HS diet, 42% of the HS-induced increase of diastolic pressure was prevented in the treated group. Heart rate was also significantly decreased ( Figure 3F ). BN (abbreviated as 13 in the bar graphs) rats maintained on a 0.4% NaCl diet (LS) or switched a 4% NaCl diet for 7 d (HS; n=3-4). Coomassie stain of the entire membrane, part of which is shown below the Western blot, was used for normalization. *P<0.05 vs 13 HS; 2-way ANOVA followed by Holm-Sidak test.
Additional groups of SS rats were treated with intrarenal administration of anti-Dnmt3a GapmeR only. The treatment tended to attenuate hypertension, but the effect appeared smaller than the effect of combined anti-Dnmt3a/ Tet3 GapmeRs and did not reach statistical significance ( Figure S6 ). In SS.13 BN26 rats, intrarenal administration of anti-Dnmt3a/Tet3 GapmeRs did not have significant effects on blood pressure on the 4% salt diet ( Figure S7 ).
Intrarenal Administration of Anti-Dnmt3a/Tet3 GapmeRs Changes DNA Methylation Patterns in the Renal Outer Medulla
We performed RRBS analysis in renal outer medulla tissues from the rats treated with GapmeRs. The group of SS rats that was treated with intrarenal administration of a scrambled GapmeR (4 mg/kg) and fed the 4% NaCl diet for 7 days was designated HS_SCR. The group treated with intrarenal administration of GapmeRs targeting Dnmt3a and Tet3 (2 mg/kg each) and fed the 4% NaCl diet for 7 days was designated HS_DT. We included in the RRBS analysis a third group of SS rats, designated 0.4% salt, that was surgically prepared in the same way as the first 2 groups but used for tissue collection just before when we would initiate the GapmeR treatment and HS diet. This third group served as the baseline for comparison.
Quality metrics for the RRBS data and bisulfite conversion rates are available in Tables S5 and S6 . On average, ≈35 million reads per library were uniquely mapped to the reference genome, and the bisulfite conversion rate was 99.9%. Approximately 2.48 million CpG sites were covered by at least 10 reads. The complete RRBS data are available in the Gene Expression Omnibus database (GSE114335).
Clustering of the samples based on the RRBS data corresponded well with the experimental grouping (Figure 4A and 4B; Table S7), suggesting reproducible shifts in methylation profiles between experimental groups. The HS_DT group and the 0.4% salt group were clustered together first. In other words, DNA methylation patterns in the HS_DT rats were more similar to the 0.4% salt group than the HS_SCR rats. Clustering based on original RRBS data without normalization produced a similar pattern of grouping ( Figure S8 ). It suggests that broad changes in de novo DNA (de)methylation 
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induced by an HS diet were substantially abolished by the administration of anti-Dnmt3a/Tet3 GapmeRs. Several DMRs were identified between each treatment group and the baseline group and between the 2 treatment groups. Approximately 20% of the DMRs were located in transcriptional start site regions, a quarter to a third in intragenic regions, and the remainder in intergenic regions ( Figure 4C through 4E) . Genomic boundaries of each DMR were defined for each comparison separately, which made it difficult to examine overlaps of DMRs across comparisons. Instead, we examined overlaps of genes bearing DMRs in transcriptional start site or intragenic regions. Of 488 genes bearing transcriptional start site or intragenic DMRs between the HS_SCR group and the 0.4% salt group, 301 genes (62%) were no longer associated with DMRs between the HS_DT group and the 0.4% salt group.
Genes bearing transcriptional start site or intragenic DMRs in each of the 3 comparisons were enriched most prominently for genes involved in transcriptional regulation (Figure 4C through 4E; Table S8 ), similar to the results shown in Figure S2 . Specifically, several GO terms, including protein binding, calcium ion binding, PDZ domain binding, RNA polymerase II regulatory region, and transcription activator activity, were significantly enriched in genes associated with DMRs in the groups treated with HS diet and scrambled GapmeR (HS_SCR) or Dnmt3a and Tet3 Gapmer (HS_DT) in comparison with the baseline group (0.4% salt). The GO term protein binding was enriched in the comparison of HS_SCR and HS_DT.
Intrarenal Administration of Anti-Dnmt3a/Tet3 GapmeRs Prevents a Large Fraction of HS-Induced Differential Gene Expression
We next performed RNA-seq analysis in the 3 groups of samples used in the RRBS analysis. Quality metrics of the RNA-seq data are available in Table S9 . On average, ≈46 million reads per library were uniquely mapped to the reference genome with a mapping rate of 92.7%. An average of 79 666 transcripts corresponding to 30 316 genomic loci was detected in each library. The complete set of the RNA-seq data are available in the Gene Expression Omnibus database (GSE114335).
Clustering of the samples based on the RNA-seq data corresponded well with the experimental grouping (Figure 5A and 5B; Table S10 ). Similar to the methylation data shown in Figure 4A , the HS_DT group and the 0.4% salt group were clustered together first, indicating mRNA expression patterns in the HS_DT rats were more similar to the 0.4% salt group than the HS_SCR rats.
Remarkably, 76% of genes, or 1294 out of 1712 genes, differentially expressed in rats treated with HS diet and scrambled GapmeR were no longer differentially expressed in rats treated with HS diet and Dnmt3a/Tet3 GapmeRs, both compared with baseline rats ( Figure 5C ). Of the 418 genes that were differentially expressed in both treatment groups compared with the baseline group, all except 2 genes were upregulated or downregulated consistently in the 2 treatment groups ( Figure S9) , indicating a high degree of reproducibility of the RNA-seq analysis.
We further examined the 1294 genes that were differentially expressed in rats treated with HS and scrambled GapmeR but not in rats treated with HS and Dnmt3a/Tet3 GapmeRs. The differential expression between rats treated with scrambled GapmeR and Dnmt3a/Tet3 GapmeRs reached statistical significance for 328 of the 1294 genes ( Figure 5D ). In other words, these 328 genes were significantly differentially expressed in response to the HS diet, which was significantly reversed by intrarenal administration of anti-Dnmt3a/Tet3 GapmeRs. We focused the next analysis on these 328 genes.
The 328 genes were enriched for genes related to several pathways, most notably pathways involved in the regulation of cellular metabolism, inflammation, and extracellular matrix ( Figure S10A ). The 328 genes were also enriched for genes related to cardiovascular, metabolic, inflammatory, and renal diseases ( Figure S10B) . Of the 328 genes, 12 were associated with transcriptional start site or intragenic regions that were differentially methylated between the 2 treatment groups ( Figure 6 ). The proportion, 12/328 or 3.7%, was significantly higher than what could be expected by chance from all DMRs and genes detected (528/30 316 or 1.7%; P=0.01, Fisher exact test).
Cloning-based bisulfite sequencing was performed to further examine 5 CpG sites in a DMR associated with Lrp2. Methylation rates at these CpG sites calculated from cloningbased bisulfite sequencing were consistent with the RRBS analysis ( Figure S11 ). The methylation level of the region was significantly decreased in rats treated with Dnmt3a/Tet3 GapmeRs compared with the scrambled GapmeR, which was consistent with the finding of the RRBS analysis ( Figure S11 ).
Discussion
We have established functional significance of de novo DNA (de)methylation in a classic model of cardiovascular disease in the present study, which should help to shift the paradigm of DNA methylation research in cardiovascular and other diseases involving nondividing cells from correlative analysis to functional, mechanistic, and therapeutic studies.
Numerous studies had shown associations between diseases, such as cardiovascular diseases and changes in DNA methylation in tissues consisting primarily of nondividing cells. 5, 13, [36] [37] [38] In the case of blood pressure, a study of blood cell DNA methylation in several thousand subjects identified CpG sites associated with systolic or diastolic blood pressure, which explained up to 2% of blood pressure variation beyond what could be explained by known blood pressure genetic variants. 39 Importantly, Mendelian randomization in that study suggested methylation at a specific CpG site might influence blood pressure while blood pressure might influence methylation at other CpG sites.
Before the present study, however, it was unknown whether de novo DNA (de)methylation in adult tissues could functionally contribute to the development of diseases, including cardiovascular disease. The administration of antiDnmt3a/Tet3 GapmeRs enabled us to demonstrate a causal, functional contribution of DNA de novo (de)methylation to the changes of DNA methylation and gene expression and the development of hypertension in the present study. Dnmt3a and Tet3 do not have any major known biochemical functions other than catalyzing de novo DNA methylation and demethylation. In addition, the vast majority of cells in the kidney are terminally differentiated cells, in which maintenance of DNA methylation during cell division is not relevant. Therefore, the phenotypic and genomic effects of anti-Dnmt3a/Tet3 GapmeRs that we observed were likely the consequences of changing de novo DNA (de)methylation. 3 GapmeRs results in differential methylation in the renal outer medulla of SS rats. A, Heatmap based on DNA methylation profiles in the renal outer medulla. Each row represents a cytosine-guanine (CpG) site, and each column depicts methylation data from an individual rat. The color bar at the top of the graph indicates grouping of rats based on experimental conditions. B, Principal component analysis using DNA methylation profiles in the renal outer medulla. Each dot indicates a sample. Samples with the same color belong to the same group of rats. C through E, Number and associated Gene Ontology terms for genomic regions differentially methylated in the HS_SCR group compared with the 0.4% salt group (C), the HS_DT group compared with the 0.4% salt group (D), and the HS_SCR group compared with HS_DT group (E). HS_SCR, SS rats treated with intrarenal administration of a scrambled GapmeR (4 mg/kg) and fed the 4% NaCl diet for 7 d; HS_DT, SS rats treated with intrarenal administration of GapmeRs targeting Dnmt3a and Tet3 (2 mg/kg each) and fed the 4% NaCl diet for 7 d; 0.4% salt, SS rats surgically prepared in the same way as rats in HS_SCR and HS_DT groups but used for tissue collection just before when GapmeR and high-salt (HS) diet would have been given; BH indicates Benjamini-Hochberg method; DMR, differentially methylated regions; GOTERM_MF, molecular function terms in Gene Ontology; and TSS, transcriptional start site regions.
The GapmeR administration approach we used allowed us to achieve modest, potentially physiologically relevant knockdown and to do so at the time of exposure to disease-inducing stimuli and thus avoid lethal or developmental effects of complete loss of Dnmt3a or Tet3. Dnmt3a catalyzes the conversion of cytosine to 5-methylcytosine (5mC). Tet3 catalyzes the conversion of 5mC to 5-hydroxymethylcytosine. RRBS does not distinguish 5mC from 5-hydroxymethylcytosine. However, we have shown previously that DNA methylation in the renal outer medulla detected by RRBS was predominantly 5mC. 13 In addition, 5-hydroxymethylcytosine is a transient modification in the process of demethylation. Therefore, the potential value of distinguishing 5mC from 5-hydroxymethylcytosine might be limited for the present study.
We administered a combination of anti-Dnmt3a and antiTet3 GapmeRs. The knockdown efficiency of Dnmt3a in the renal outer medulla was clear-cut while the efficiency for Tet3 was less certain because of questionable Western blots. Dnmt3a in the kidney can be regulated by known regulators of blood pressure, such as Ang II (angiotensin II). 40 Anti-Dnmt3a alone did not have the clear effect of combined anti-Dnmt3a/ Tet3 on hypertension. It would be valuable to investigate the specific role of other isoforms of Dnmt3 and Tet individually in future studies, including isoforms, that were not differentially expressed between SS and SS. 13 BN rats. The isoforms that are not differentially expressed could still play a permissive role in the changes of DNA methylation that are important for disease development. Future studies should also aim to investigate the functional role of methylation changes in specific cell types or at specific genomic loci. Unfortunately, conditional, cell type-specific deletion of genes remains nearly impossible to produce in rats. It is challenging, but possible, to experimentally alter methylation levels at specific genomic loci in cultured cells. 41, 42 Doing so in animal models in vivo is much harder, although recent advances in technologies suggest it might be feasible. 42 Secondary effects of the difference in blood pressure between SS rats treated with scrambled GapmeR and Dnmt3a/ Tet3 GapmeRs could contribute to some of the differential expression or methylation between the 2 groups. However, while about one-third of salt-induced increase of blood pressure was prevented by intrarenal administration of anti-Dnmt3a/Tet3 GapmeRs, salt-induced differential expression was prevented for 3 quarters of the genes. In addition, genes differentially expressed between rats treated with scrambled or Dnmt3a/Tet3 GapmeRs were statistically enriched for genes associated with differential methylation. These findings suggest the administration of anti-Dnmt3a/Tet3 likely contributed to the changes in DNA methylation and subsequent differential gene expression. Several of the genes showing both differential expression and differential methylation are known to be important in the regulation of blood pressure or related physiological processes. For example, Gss encodes glutathione synthase. Glutathione is a key antioxidant, and oxidative stress in the kidney is known to contribute to hypertension in SS rats. 28 Apln encodes apelin, which is known to regulate water and electrolyte homeostasis via mechanisms in neuroendocrine systems and the kidneys. 43, 44 Lrp2 encodes megalin, which is highly expressed in the renal proximal tubules, including proximal straight tubules that are present in the outer medulla, and important for hormone binding and cell signaling. 45 Differential expression of genes that were not associated with differential methylation might represent secondary effects of changes in genes that were directly influenced by methylation changes. The differentially expressed genes in response to the administration of anti-Dnmt3a/Tet3
GapmeRs were enriched for genes related to cellular metabolism, inflammation, and extracellular matrix, which is consistent with pathways known to be altered in the kidneys of SS rats and contribute to the development of disease phenotypes of SS rats.
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Perspectives
The findings of the present study indicate DNA de novo (de) methylation in the kidney contributes to the development of hypertension in SS rats. The study provides some of the first evidence for a functional role of DNA de novo (de)methylation in adult diseases. Commonly used methylation inhibitors could cause broad loss of methylation patterns important for maintaining the identities and normal functions of cells. Specific targeting of DNA de novo (de)methylation may ameliorate disease while avoiding the toxic effect of currently available methylation inhibitors. . Genes significantly differentially expressed and differentially methylated in response to intrarenal administration of anti-DNA methyltransferase 3 (Dnmt3)a/ten-eleven translocase (Tet)3 GapmeRs. Twelve of the 328 differential expressed genes shown in D of Figure 5 were associated with genomic regions differentially methylated between rats treated with scrambled GapmeR (HS_SCR) and GapmeRs targeting Dnmt3a and Tet3 (HS_DT). The difference between the 2 groups was statistically significant (false discovery rate <0.05) in each (mean values were plotted). All differentially methylated regions are located in intragenic regions, except that the regions associated with Adamts9 and XLOC_022899 are located in transcriptional start site regions. FPKM indicates fragments per kilobase per million reads.
